Prof. Junbo Ge, China's leading expert in cardiology and an Academician of the Chinese Academy of Sciences, finished two complex coronary intervention procedures at DeltaHealth Hospital·
Bayer AG and its cooperation partner Janssen Research & Development, LLC have announced that the Phase III trial COMPASS evaluating the efficacy and safety of rivaroxaban (Xarelto?) for the prevention of major adverse cardiac events (MACE)...
Novartis announced a collaboration and option agreement with Ionis Pharmaceuticals, Inc. and its affiliate Akcea Therapeutics, Inc., to license two novel treatments...
The US Food and Drug Administration (FDA) approved supplemental new drug applications for three type 2 diabetes medicines within the empagliflozin family to include data from the empa-red outcome trial.